-
Crash and burn: Pakistan cricket at a new low after England humiliation
-
One dead, 102 rescued from stricken ferry off Indonesia's Java
-
'Second life': Nepal tunnel survivor recalls ordeal
-
Garcia keeps WBC welterweight title by stopping Benn
-
Hong Kong homes flattened for US$28 bn high-tech hub
-
Lights out in Laos as electricity exports surge
-
'Be careful what you wish for': 'Obsession' director and star reflect on success
-
'This is the test': All eyes on US Fed to tackle high inflation
-
Messi scores but Miami held by Nashville
-
Scars of Marawi siege linger as Philippines poll nears
-
US Open champ Rybakina on top of world after injury scare
-
Trump turns to golf, family business on Irish visit's second day
-
Rybakina reigns serene as new world number one
-
Best Online Gold Dealers in USA 2026 Rankings Released By Experts
-
Defiant Sabalenka motivated by US Open defeat
-
South Africa defeat New Zealand 43-28 to complete 3-1 series victory
-
Houthis say hit Saudi base after renewed fighting with Yemeni govt forces
-
Rybakina triumphs in US Open, denies Sabalenka three-peat
-
Maryland groups seek statewide data center pause after local moratoriums spread
-
Mini 1998 GT pairs 161-hp engine with John Cooper Works chassis hardware
-
Japanese floating parking platform is designed to lift cars above floodwater
-
GTA VI draws political criticism online as preorder estimates exceed five million
-
Anthropic details Claude misuse as US targets major illicit online marketplace
-
Steven Strogatz weighs AI mathematics advances and their consequences for researchers
-
Fifth Circuit upholds dismissal of Jackson residents' constitutional water claims
-
KFF journalists discuss opioid funds, suicide prevention and gaps in care
-
Winston County trash-debt prosecutions face challenge from civil-rights lawyers
-
Roadless Rule repeal proposal raises concerns over Midwest forests and fire risk
-
Utah hosts Arkansas as both programs begin seasons under new coaches
-
Queens residents seek renewed enforcement along Roosevelt Avenue
-
Christa Pike seeks clemency before September 30 execution in Tennessee
-
United States beats Spain 76-66 to set up World Cup final against France
-
Louisiana's developing roster faces USC as Trojans enter as heavy favorites
-
Cristian Mungiu's Fjord examines a family's conflict with Norwegian child authorities
-
Akron fan's honorary play-calling stint ends with opening-drive fumble
-
Gilbert Arenas questions Jonathan Kuminga's decision to join Minnesota
-
Marmot research gains over $140,000 from meme-coin fees alongside wildlife contest
-
Arteta blasts 'unacceptable' Sunderland penalty despite Arsenal win
-
Attissogbe double inspires Pau to Top 14 summit
-
Mbappe at the double as Real Madrid sink Rayo
-
Guimaraes strike lights up Arsenal win over Sunderland
-
Arsenal extend perfect Premier League start as Chelsea, Liverpool held
-
Israeli-made Gaza documentary wins Venice special jury prize
-
US survive Spain scare to book World Cup final clash with France
-
De Zerbi apologises to fans after Spurs' stalemate extends goal drought
-
Celine Dion makes long-awaited return to stage in Paris
-
Lowry takes four-shot lead as Trump jets in for Irish Open
-
Werro crowned Ultimate queen, US sweep 100m races
-
Harrison, Skupski win US Open men's doubles title
-
Venezuelans outside Caracas say capital not sharing blackout burden
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
A.Clark--AT